From the Sector

The European Chemicals Agency (ECHA) has found that substances causing cancer, genetic mutations or harming reproduction are present in childcare products, such as car seats, bibs and baby changing mats. Its investigation will help the European Commission to prepare an EU-wide restriction to limit these chemicals, with the aim of safeguarding children.

ECHA’s investigation, drawing on information from 48 different sources, shows that substances which are carcinogenic, mutagenic or toxic for reproduction (CMR) may be present in childcare products (articles). Metals like cobalt and lead, along with phthalates like DEHP, are the most common CMR substances found in childcare products.

CMRs were most often found in items like car seats, bibs, products related to toiletries, and bedding and mattresses. Children may be exposed to these hazardous substances during use, for example through skin or oral contact, and are particularly vulnerable to the harm caused by chemical substances because of their small size, developing physiology and behaviour.

ECHA’s report provides elements to support the European Commission in the preparation of a potential future restriction. These include information on how childcare articles are defined, what the restriction could cover, potential derogations, recommended concentration limits and timeframes for implementation. The report also includes views from ECHA’s Enforcement Forum on how feasible it would be to enforce such a restriction.

The report will now be sent to the European Commission, who will use it to prepare a draft restriction proposal under REACH Article 68(2). This procedure allows the Commission to prepare a restriction proposal without involvement of ECHA’s scientific committees.

Background
The purpose of ECHA’s investigation is to support the European Commission in preparing a restriction under the REACH Regulation to protect children from exposure to CMR substances in childcare articles. It focused on substances that have a harmonised classification under the Classification, Labelling and Packaging (CLP) Regulation as a CMR in category 1A (known human carcinogen, mutagen or reproductive toxicant) or 1B (presumed human carcinogen, mutagen or reproductive toxicant).

During the investigation, ECHA organised two public calls for evidence and a consultation on the draft report. The Agency contacted 233 different stakeholders to inform about the work and considered their feedback.

İşbir Bedding, a Turkish company, has teamed up with Hologenix® and its CELLIANT® infrared technology. The Energy CELLIANT® mattress is the first pure white CELLIANT mattress to be offered in Turkey. It marries the sleep technology of İşbir mattresses with the advantages of CELLIANT, a natural blend of bioceramic minerals which, when embedded into textiles, converts body heat into infrared energy to help consumers sleep better and recover faster from physical activity.

the Energy CELLIANT mattress has a cover infused with CELLIANT, a high-density, next-generation ViscoStar Aeromax Comfort Layer that adapts to the body and a V2 Active Zone Pocket Spring Support Layer, which consists of specially designed 7-zone pocket springs. The Energy CELLIANT mattress is suitable for any sleep position and ideal for users who prefer a medium to firm mattress. The mattress is also available in a variety of sizes for both junior and adult athletes.

The Energy CELLIANT mattress helps the body recover after sports or intense activity thanks to the infrared technology and comfort layers. The CELLIANT fabric helps the body thermoregulate, whether you run hot or cold, for a more comfortable sleep experience. CELLIANT minerals help to increase energy levels by reflecting body heat lost during sleep back to the body in the form of infrared energy, so consumers wake up refreshed.

HeiQ Allergen* Tech will power a new and improved generation of Purotex, a BekaertDeslee product through its exclusive application to mattress ticking aiming to provide end-users with a good night’s sleep.

HeiQ Materials AG  has signed an Exclusive Supply Agreement with BekaertDeslee, a specialist in the development and manufacturing of mattress textiles, mattress covers, and on-trend sleep solutions, for the supply of HeiQ’s recently launched HeiQ Allergen* Tech.  

Under this agreement, BekaertDeslee will have exclusive worldwide rights to apply HeiQ Allergen* Tech to mattress ticking, which is used to cover mattresses. HeiQ Allergen* Tech, which was launched in October 2022, is a 100% biobased, naturally derived technology that reduces exposure to inanimate allergens such as house dust mite matter, and pet allergens with the help of active probiotics.

It has been granted the Allergy UK Seal of Approval by The British Allergy Foundation following a review and assessment of the technology. Additionally, an independent certification has shown that HeiQ Allergen* Tech successfully reduces 83,6% of cat (hair) allergen, 76,5% of dog (hair) allergen, and 96,6% of house dust mite matter allergen.

* Inanimate allergens such as house dust mite matter & pet allergens.

The sustainable collaboration and innovation between Indorama Ventures (IVL), Auping and TWE Group presented a certified cradle to cradle process for mattress components across nonwoven applications, at Techtextil, Frankfurt, 21st to 24th June 2022.

Using circular research and design, the industry partnership between IVL Mullagh (Ireland), Auping and TWE Group has resulted in a perpetual, sustainable economic business model, for manufacturers globally. The inclusion of safe raw materials within mattress manufacturing allows the materials to be easily disassembled at the product’s end of use in order to be further reused as same components or recycled into new raw material at the same quality level, to enable versatile textile applications.

Designed for disassembly to optimize the use of existing resources, reduce carbon footprint and support customer objectives all along their customers’ supply chain. This circular industry collaboration begins with design, where the mattress is constructed using only two different base materials, 100% PET polyester textiles and steel wire pocket springs connected with Niaga®️, a non toxic reversible adhesive, making the mattress easy to disassemble and recover.

IVL, Auping and TWE’s shared vision for a better world is demonstrated through their connected and innovative circularity that helps to close the loop. Auping collects, sorts and separates the collected fabrics, which then go to IVL Mullagh for processing, melting and extrusion to form polyester staple fiber. These staple fibers are then converted by TWE Group into nonwovens for use in Auping’s Evolve mattress, a fully circular mattress. Following the end of mattress use, the material recovery process simply starts again.

Auping estimates that annually more than 40 million mattresses are disposed of in Europe alone, the majority of which are incinerated. Their take back system in the Netherlands ensures that when their new mattress is delivered, the old mattress is retrieved and recycled, irrespective of the brand, ensuring existing materials are continually optimized, diverted from landfill and kept in use to achieve a circular economy.

The antimicrobial protection of Sanitized® T 99-19 against the SARS-CoV-2 virus has been confirmed by independent labs in France (basis: ISO 18184:2019).

Textile and polymer products with Sanitized® antimicrobial treatment have been used in hygiene-sensitive areas for many years. For textiles, Sanitized® T 99-19 is a patented technology based on a silane-ammonia compound, a globally proven product. Its hygiene function is used in workwear and protective clothing for nursing staff, bed linen or mattresses in hotels, nursing care facilities and hospitals. Polyester goods for precisely these areas of application can now not only be antimicrobial, but also reliably protective against SARS CoV-2.

The antiviral efficacy (99.84 %) of the Sanitized® T 99-19 product has been officially confirmed by tests conducted by external labs.

Tests on end products, which were additionally carried out by textile manufacturers, also prove the effectiveness of Sanitized® T 99-19 against SARS CoV-2. License partners praise this confidence-building benefit of the end products. SANITIZED license partners receive concrete support in terms of marketing and legal aspects (health claims).

Avoid legal pitfalls when claiming antiviral protection
Advice and support for customers in achieving optimal hygiene protection for their products are an integral part of SANITIZED services. A claim guide has therefore been developed especially for products that protect against COVID-19.
https://www.sanitized.com/de/protection-against-covid-19-which-antiviral-advertising-claimsare-legal-sanitized-explains/